NDC 69097-920 – Liraglutide

Liraglutide 6 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC69097-920

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Cipla USA Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA217590
Marketed since
January 22, 2026
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
69097-920-672 SYRINGE, PLASTIC in 1 CARTON (69097-920-67) / 3 mL in 1 SYRINGE, PLASTICJan 22, 2026
69097-920-683 SYRINGE, PLASTIC in 1 CARTON (69097-920-68) / 3 mL in 1 SYRINGE, PLASTICJan 22, 2026

Other Liraglutide products